CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Haisco Pharmaceutical Group Co Ltd Company Snapshot
Haisco Pharmaceutical Group Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Haisco Pharmaceutical Group Co Ltd with three other companies in this sector in China: Shanghai Kaibao Pharmaceutical Company Limited (2016 sales of 1.50 billion Chinese Renmimbi [US$227.73 million] of which 100% was Industrial), Guilin Sanjin Pharmaceutical Co Ltd (1.53 billion Chinese Renmimbi [US$232.00 million] of which 94% was Proprietary Chinese medicine), and Jinhe Biotechnology Co Ltd (1.50 billion Chinese Renmimbi [US$227.45 million] of which 72% was Medical Feeds Additives).

Sales Analysis. During the year ended December of 2016, sales at Haisco Pharmaceutical Group Co Ltd were 1.44 billion Chinese Renmimbi (US$218.37 million). This is an increase of 18.4% versus 2015, when the company's sales were 1.21 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Haisco Pharmaceutical Group Co Ltd (and since 2011, sales have increased a total of 138%). Sales of Pharmacy saw an increase of 18.4% in 2016, from 1.21 billion Chinese Renmimbi to 1.44 billion Chinese Renmimbi. Not all segments of Haisco Pharmaceutical Group Co Ltd experienced an increase in sales in 2016: sales of Other Operating fell 20.1% to 532,017.10 Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Haisco Pharmaceutical Group Co Ltd
  Stock Performance Chart for Haisco Pharmaceutical Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/15/2017): 12.90
(Figures in Chinese Renmimbi)
1 Week 0.2%   13 Weeks 6.1%  
4 Weeks -1.4%   52 Weeks -23.8%  
 
Haisco Pharmaceutical Group Co Ltd Key Data:
  Ticker: 002653 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,435,582,787
(Year Ending Jan 2017).
Employees: 1,868
  Currency: Chinese Renmimbi Market Cap: 13,797,989,898
  Fiscal Yr Ends: December Shares Outstanding: 1,069,611,620
  Share Type: A Gu Closely Held Shares: 923,363,239
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.